EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Human Milk Fortification and Necrotizing Enterocolitis in Very Low Birthweight Infants: State of Evidence and Systematic Review with Meta-Analysis

Sarah M Reyes iD, Tristen L Paul, Jenelle Ferry iD

Nutrients · 2025

DOI: 10.3390/nu17213384 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, 2025. Verfasst von Sarah M Reyes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rev Bioscience, LLC, Boise, ID 83712, USA. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Food, Fortified, Infant, Very Low Birth Weight, Milk, Human. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prolacta Bioscience, Prolacta Bioscience, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Necrotizing enterocolitis (NEC) remains a leading cause of morbidity and mortality in very low birthweight (VLBW) infants. Human milk feeding and standardized feeding protocols are protective, but clinical practice varies, particularly in fortifier choice. Whether human milk-derived fortifiers reduce NEC risk compared with cow milk-derived fortifiers remains unclear.

Methods

We conducted a systematic state-of-evidence review and meta-analysis, searching PubMed, Web of Science, and Scopus through July 2025. Eligible studies included RCTs and observational cohorts of VLBW infants comparing an exclusive human milk diet (EHMD) including human milk-derived fortifiers to cow milk-derived diets. Two reviewers independently screened and extracted data. Both RCTs and observational studies were included to evaluate consistency of effect estimates across designs and to account for heterogeneity in control group feeding practices. Pooled odds ratios (ORs) with 95% CIs were calculated using a Sidik–Jonkman random-effects model. Sensitivity analyses by study design and exclusion of infant formula from controls were performed.

Results

Twenty studies (five RCTs, 15 observational; n = 6794 infants) met inclusion criteria, most enrolling infants born ≤1250 g. Compared with cow milk-containing diets, EHMD was associated with lower odds of Bell Stage ≥ 2 NEC (OR: 0.59; 95% CI: 0.42, 0.81; p < 0.001; n = 4625) and surgical NEC (OR: 0.43; 95% CI: 0.32, 0.58; p < 0.0001; n = 4754). In direct comparisons of fortifier type with a base diet of human milk, estimates suggested lower odds of Bell Stage ≥ 2 NEC by 35% (OR: 0.65; 95% CI: 0.44, 0.97; p = 0.03, n = 2102) and surgical NEC by 49% (OR: 0.51; 95% CI: 0.26, 0.98; p = 0.04; n = 1659) with human milk-derived fortifiers. Effect estimates were generally consistent across study designs, although precision and statistical significance varied.

Conclusions

EHMD with human milk-derived fortifiers was associated with lower odds of medical and surgical NEC in VLBW infants, with most evidence from infants born ≤1250 g, reflecting current clinical use in the highest-risk population. Although the number and sample sizes of RCTs remain limited, the consistency of effect estimates across both RCTs and observational studies, together with significance of pooled analyses, strengthens confidence in these findings. Pragmatic and registry-based studies using standardized fortification protocols may provide the most efficient pathway to strengthen the evidence base.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterocolitis, NecrotizingFood, FortifiedInfant, Very Low Birth WeightMilk, HumanAnimalsHumansInfant, NewbornInfant FormulaInfant Nutritional Physiological PhenomenaInfant, PrematureMilkObservational Studies as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

exclusive human milk diethuman milk fortifiernecrotizing enterocolitispremature infantvery low birthweight

Autor:innen und Institutionen

  • Rev Bioscience, LLC, Boise, ID 83712, USA.
  • Pediatrix Medical Group Tampa Regional Practices, St. Joseph's Women's Hospital, Tampa, FL 33607, USA.

ORCID-Profile: Sarah M Reyes, Jenelle Ferry

Förderung

  • Prolacta Bioscience
  • Prolacta Bioscience, Inc.

Zitieren

APA

Reyes, S. M., Paul, T. L., & Ferry, J. (2025). Human Milk Fortification and Necrotizing Enterocolitis in Very Low Birthweight Infants: State of Evidence and Systematic Review with Meta-Analysis. Nutrients. https://doi.org/10.3390/nu17213384

Vancouver

Reyes SM, Paul TL, Ferry J. Human Milk Fortification and Necrotizing Enterocolitis in Very Low Birthweight Infants: State of Evidence and Systematic Review with Meta-Analysis. Nutrients. 2025. doi:10.3390/nu17213384

BibTeX
@article{Reyes2025,
  author = {Reyes, Sarah M and Paul, Tristen L and Ferry, Jenelle},
  title = {Human Milk Fortification and Necrotizing Enterocolitis in Very Low Birthweight Infants: State of Evidence and Systematic Review with Meta-Analysis},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17213384}
}
Kostenlos starten →